Liver Diseases  >>  everolimus  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
everolimus / Generic mfg.
EVOLVE-1, NCT01035229 / 2009-010196-25: Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.

Checkmark In adv HCC after failure of sorafenib
Jul 2014 - Jul 2014: In adv HCC after failure of sorafenib
Checkmark ASCO-GI 2014
Jan 2014 - Jan 2014: ASCO-GI 2014
Checkmark Vs. PBO in pts with locally adv/mets HCC after progression on or intolerance to sorafenib
More
Completed
3
546
Japan, US, Canada, Europe, RoW
Everolimus, RAD001, Everolimus Placebo, Best Supportive Care (BSC)
Novartis Pharmaceuticals
Carcinoma
10/13
10/13

Download Options